Mamta Singla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mamta Singla has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Adelaida R. Palla
Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA
1 shared publication - Akshay Pandey
Department of Orthopaedic Surgery, Stanford University, Stanford, CA, USA
1 shared publication - Elena Monti
Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA
1 shared publication - Helen M. Blau
Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, USA
1 shared publication - Maiko Hermsmeier
Department of Orthopaedic Surgery, Stanford University, Stanford, CA, USA
1 shared publication - Mohsen Afshar Bakooshli
Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada
1 shared publication
Latest Publications
- Top Cited Papers
- 5 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 391 (6789) , 1053-1062
Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration
Aging or injury to the joints can lead to cartilage degeneration and osteoarthritis (OA), for which there are limited effective treatments. We found that expression of 15-hydroxy prostaglandin dehydrogenase (15-PGDH) is increased in the articular cartilage of aged or injured mice. Both systemic and local inhibition of 15-PGDH with a small-molecule inhibitor (PGDHi) led to regeneration of articular cartilage and reduction in OA-associated pain. Using single-cell RNA-sequencing and multiplexed immunofluorescence imaging of cartilage, we identified the major chondrocyte subpopulations. Inhibition of 15-PGDH decreased hypertrophic-like chondrocytes expressing 15-PGDH and increased extracellular matrix–synthesizing articular chondrocytes. Cartilage regeneration appears to occur through gene expression changes in preexisting chondrocytes, rather than stem or progenitor cell proliferation. 15-PGDH inhibition could be a potential disease-modifying and regenerative approach for osteoarthritis.
- 5 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 391 (6789) , 1053-1062
Top Cited PapersInhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration
Aging or injury to the joints can lead to cartilage degeneration and osteoarthritis (OA), for which there are limited effective treatments. We found that expression of 15-hydroxy prostaglandin dehydrogenase (15-PGDH) is increased in the articular cartilage of aged or injured mice. Both systemic and local inhibition of 15-PGDH with a small-molecule inhibitor (PGDHi) led to regeneration of articular cartilage and reduction in OA-associated pain. Using single-cell RNA-sequencing and multiplexed immunofluorescence imaging of cartilage, we identified the major chondrocyte subpopulations. Inhibition of 15-PGDH decreased hypertrophic-like chondrocytes expressing 15-PGDH and increased extracellular matrix–synthesizing articular chondrocytes. Cartilage regeneration appears to occur through gene expression changes in preexisting chondrocytes, rather than stem or progenitor cell proliferation. 15-PGDH inhibition could be a potential disease-modifying and regenerative approach for osteoarthritis.